| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Atorvastatin | FAERS: 2 | US FAERS | |
| 2 | Rivaroxaban | FAERS: 2 | US FAERS | |
| 3 | Alendronate | FAERS: 1 | US FAERS | |
| 4 | Pregabalin | FAERS: 1 | US FAERS | |
| 5 | ledipasvir, sofosbuvir drug combination | FAERS: 1 | US FAERS | |
| 6 | niraparib | FAERS: 1 | US FAERS | |
| 7 | palbociclib | FAERS: 1 | US FAERS | |
| 8 | rucaparib | FAERS: 1 | US FAERS | |
| 9 | Maprotiline | OFFSIDES | ||
| 10 | Thiothixene | OFFSIDES | ||
| 11 | pirbuterol | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120265
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.